Zorvolex for OA Approved by FDA

(MedPage Today) -- The FDA today approved a new low-dose formulation of diclofenac (Zorvolex) for the treatment of osteoarthritis pain, manufacturer Iroko Pharmaceuticals announced.
Source: MedPage Today Geriatrics - Category: Geriatrics Source Type: news